Top Markets
Coin of the day
Cotinga Pharmaceuticals Inc. Cotinga Pharmaceuticals Inc.

Cotinga Pharmaceuticals Inc.

COTQF
주식 순위 #42319
Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused... Cotinga Pharmaceuticals Inc. is a clinical-stage biopharmaceutical firm focused on developing innovative treatments for cancer and other medical conditions currently lacking adequate solutions. Its leading therapeutic asset is COTI-2, an oral small molecule formulated to target the p53 tumor suppressor gene. The company is also progressing COTI-219, another oral small molecule compound, specifically engineered to inhibit mutant forms of KRAS without affecting the normal functions of the KRAS gene. In collaboration with St. Vincent's University Hospital, Cotinga is conducting research to evaluate COTI-2 when combined with eribulin for patients suffering from triple-negative metastatic breast cancer. The company, which was previously known as Critical Outcome Technologies Inc., rebranded to Cotinga Pharmaceuticals Inc. in January 2018. Its corporate base is situated in Toronto, Canada.
주가
$0.0001
마지막 동기화: 2026-07-02
시가총액
$2.20K
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
CA
거래 Cotinga Pharmaceuticals Inc. (COTQF)

카테고리

Cotinga Pharmaceuticals Inc. (COTQF)의 주식 분할 이력
Cotinga Pharmaceuticals Inc. 주식 (심볼: COTQF)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 12, 2026에 발생했습니다.
Aug 12, 2026 이전에 매수한 COTQF 주식 1주는 현재 0주의 COTQF 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
1 x2
US
0 -
NL
0 -
CH
0 -
BE
0 -
KR